Drugmaker, FDA Agree On Terms To Fix Production Issues
Ben Venue Laboratories Inc. and federal regulators on Tuesday struck a deal in which the company agreed not to resume full drug manufacturing operations at its Ohio plant until proving it...To view the full article, register now.
Already a subscriber? Click here to view full article